GLENMARK PHARMACEUTICALS LTD. - Glenmarks TRPA1 antagonist GRC 17536 shows positive data in a proof of concept study

17 Sep 2014

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated September 17, 2014 titled "Glenmarks TRPA1 antagonist GRC 17536 shows positive data in a proof of concept study".

Source: BSE India

View all announcements for GLENMARK PHARMACEUTICALS LTD.

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist